ID
36393
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the concomitant medication form. It has to be filled in if the subject takes concomitant medication during the study.
Mots-clés
Versions (2)
- 05/09/2017 05/09/2017 -
- 10/05/2019 10/05/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
10 mai 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Concomitant Medication
- StudyEvent: ODM
Description
CONCOMITANT MEDICATION
Alias
- UMLS CUI-1
- C2347852
Description
If ‘Yes’, please record all medications below. When appropriate, medical conditions should be recorded on the Adverse Event form, utilising the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Type de données
text
Alias
- UMLS CUI [1]
- C2347852
Description
(Trade name preferred)
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
Description
Single dose/unit
Type de données
text
Alias
- UMLS CUI [1]
- C1960417
Description
dose frequency
Type de données
text
Alias
- UMLS CUI [1]
- C2826654
Description
Route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Indication
Type de données
text
Alias
- UMLS CUI [1]
- C3146298
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0013227
Description
00.00-23:59
Type de données
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0013227
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Description
00:00-23:59
Type de données
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0013227
Similar models
Concomitant Medication
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])